Home/Filings/4/0001415889-17-001785
4//SEC Filing

Spoor Johan M. 4

Accession 0001415889-17-001785

CIK 0001604191other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:20 PM ET

Size

9.1 KB

Accession

0001415889-17-001785

Insider Transaction Report

Form 4
Period: 2017-11-10
Spoor Johan M.
DirectorPresident and CEO
Transactions
  • Exercise of In-Money

    Common Stock

    2017-11-10$1.00/sh+100,000$100,000100,034 total
  • Exercise of In-Money

    Options

    2017-11-10100,000200,000 total
    Exercise: $1.00Exp: 2021-01-04Common Stock (100,000 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    39,851
  • Options

    Exercise: $4.48From: 2017-02-03Exp: 2027-02-03Common Stock (100,000 underlying)
    100,000
Footnotes (3)
  • [F1]Held by the Reporting Person's mother for his minor children under the Uniform Transfers to Minors Act. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interests therein.
  • [F2]Represents options granted to the Reporting Person by third parties.
  • [F3]Immediately exercisable.

Issuer

AzurRx BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001535289

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 6:20 PM ET
Size
9.1 KB